Get started
Author

Catherine J. Drummond

Observed names: C J Drummond, CJ Drummond, Catherine Drummond, Catherine J Drummond, Drummond, C.J.
Observed institutions: St. Jude Children's Research Hospital, University of Auckland, University of St Andrews, University of Dundee, Ninewells Hospital, Karolinska Institutet, Maurice Wilkins Centre, University of Otago, Newcastle University
ORCID: 0000-0002-7019-3173
Observed ORCID: 0000-0002-7019-3173
OpenAlex ID: A5000215412
Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein−Protein Interaction: Structure−Activity Studies Leading to Improved Potency
2011 · Ian R. Hardcastle, Junfeng Liu, et al. · Journal of Medicinal Chemistry · 152
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
2018 · Marcus J. G. W. Ladds, Ingeborg M. M. van Leeuwen, et al. · Nature Communications · 90
PDF
Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors
2018 · Catherine J. Drummond, Jason A. Hanna, et al. · Cancer Cell · 89
PDF
Adaptive homeostasis and the p53 isoform network
2021 · Sunali Mehta, Hamish Campbell, et al. · EMBO Reports · 49
PDF
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
2019 · Marina Kazantseva, Sunali Mehta, et al. · Cell Death and Disease · 47
PDF
MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones
2011 · Anna F. Watson, Junfeng Liu, et al. · Bioorganic & Medicinal Chemistry Letters · 47
Tenovin-D3, a Novel Small-Molecule Inhibitor of Sirtuin SirT2, Increases p21 ( CDKN1A ) Expression in a p53-Independent Manner
2013 · Anna R. McCarthy, Marijke C.C. Sachweh, et al. · Molecular Cancer Therapeutics · 42
DNA-Binding Anticancer Drugs: One Target, Two Actions
2021 · Bruce C. Baguley, Catherine J. Drummond, et al. · Molecules · 39
PDF
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression
2013 · M C C Sachweh, C J Drummond, et al. · Cell Death and Disease · 39
PDF
PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
2023 · Madeline B. Searcy, Randolph K. Larsen, et al. · Nature Communications · 38
PDF
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells
2015 · Marijke C.C. Sachweh, William C. Stafford, et al. · Oncotarget · 33
PDF
Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
2020 · Ramona A. Eiholzer, Sunali Mehta, et al. · Cancers · 30
PDF
Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity
2021 · Casey G. Langdon, Katherine E. Gadek, et al. · Nature Communications · 23
PDF
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation
2016 · Catherine J. Drummond, Arman Esfandiari, et al. · Oncotarget · 22
PDF
Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma
2017 · Jason A. Hanna, Catherine J. Drummond, et al. · Cancer Research · 21
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts
2015 · Suhas D. Darekar, Muhammad Mushtaq, et al. · Oncotarget · 17
PDF
Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide
2010 · Catherine J. Drummond, Graeme J. Finlay, et al. · Investigational New Drugs · 16
A Comparison of the Ability of DMXAA and Xanthenone Analogues to Activate NF-κB in Murine and Human Cell Lines
2005 · See-Tarn Woon, Charu B. Reddy, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 15
A Case of mistaken identity: Rhabdomyosarcoma development from endothelial progenitor cells
2018 · Catherine J. Drummond, Mark E. Hatley · Molecular & Cellular Oncology · 10
PDF
The mechanism of anti-tumour activity of the DNA binding agent SN 28049
2008 · Catherine J. Drummond · ResearchSpace (University of Auckland) · 6
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
2018 · Marcus J. G. W. Ladds, Ingeborg M. M. van Leeuwen, et al. · Nature Communications · 5
PDF
Transdifferentiation of endothelial progenitor cells into rhabdomyosarcoma defined by hedgehog signaling competence
2025 · Katherine E. Gadek, Catherine J. Drummond, et al. · Cell Reports · 4
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
2018 · Marcus J. G. W. Ladds, Andrés Pastor-Fernández, et al. · PLoS ONE · 4
PDF
Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
2023 · Marcus J. G. W. Ladds, Ingeborg M. M. van Leeuwen, et al. · Nature Communications · 3
PDF
The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma
2024 · William J. H. Davis, Catherine J. Drummond, et al. · Genes · 2
PDF
Works count: 73
Citation count: 845
H-index: 16
I10-index: 19
Year
Topic
Type